Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Peter C. Black, H.A.D.M. Ashab et al.|European Urology|2017Cited by 793
Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical OutcomeBas W.G. van Rhijn, Ellen C. Zwarthoff, Theodorus van der Kwast et al.|Journal of Clinical Oncology|2003Cited by 321
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and TherapyLucie C. Kompier, Ellen C. Zwarthoff, Irene Lurkin et al.|PLoS ONE|2010Cited by 314
<b> <i>FGFR3</i> </b> and <b> <i>P53</i> </b> Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell CarcinomaBas W.G. van Rhijn, Ellen C. Zwarthoff, Theodorus van der Kwast et al.|Cancer Research|2004Cited by 223
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder CancerBas W.G. van Rhijn, Theodorus van der Kwast, Tahlita C.M. Zuiverloon et al.|European Urology|2010Cited by 193